China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
PR Newswire•21/10/2026•08:00 ET
0
Key Highlights
- ➤$12 million additional purchase right terminated in full
- ➤Purchasers no longer can buy more Class A shares or pre-funded warrants
- ➤Offering-issued securities remain unaffected; all other terms stay unchanged
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right PR Newswire
TAIZHOU, China, Oct. 21, 2026 /PRNewswire/ -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), today announced that it has entered into a termination letter agreement with the purchasers in its registered direct offering announced on October 8, 2026 (the "Offering").
Get started
Create a free account to read the full story.